Using 4DCT-ventilation to characterize lung function changes for pediatric patients getting thoracic radiotherapy.

Abstract

PurposeA form of lung functional imaging has been developed that uses 4DCT data to calculate ventilation (4DCT‐ventilation). Because 4DCTs are acquired as standard‐of‐care to manage breathing motion during radiotherapy, 4DCT‐ventilation provides functional information at no extra dosimetric or monetary cost. 4DCT‐ventilation has yet to be described in children. 4DCT‐ventilation can be used as a tool to help assess post‐treatment lung function and predict for future clinical thoracic toxicities for pediatric patients receiving radiotherapy to the chest. The purpose of this work was to perform a preliminary evaluation of 4DCT‐ventilation‐based lung function changes for pediatric patients receiving radiotherapy to the lungs.MethodsThe study used four patients with pre and postradiotherapy 4DCTs. The 4DCTs, deformable image registration, and a density‐change‐based algorithm were used to compute pre and post‐treatment 4DCT‐ventilation images. The post‐treatment 4DCT‐ventilation images were compared to the pretreatment 4DCT‐ventilation images for a global lung response and for an intrapatient dose–response (providing an assessment for dose‐dependent regional dose–response).ResultsFor three of the four patients, a global ventilation decline of 7–37% was observed, while one patient did not demonstrate a global functional decline. Dose–response analysis did not reveal an intrapatient dose–response from 0 to 20 Gy for three patients while one patient demonstrated increased 4DCT‐ventilation decline as a function of increasing lung doses up to 50 Gy.ConclusionsCompared to adults, pediatric patients have unique lung function, dosimetric, and toxicity profiles. The presented work is the first to evaluate spatial lung function changes in pediatric patients using 4DCT‐ventilation and showed lung function changes for three of the four patients. The early changes demonstrated with lung function imaging warrant further longitudinal work to determine whether the imaging‐based early changes can be predicted for long‐term clinical toxicity.